Azitra (AZTR) Cash from Operations (2022 - 2026)
Azitra (AZTR) reported Cash from Operations of 2477304.0 for Q1 2026, up 19.35% on a YoY basis from 2075622.38 in Q1 2025, and up 14.36% quarter-over-quarter from 2892611.0 in Q4 2025.
Azitra (AZTR) Cash from Operations (2022 - 2026) Analysis & Trends
Azitra has reported Cash from Operations for 5 years, with the latest figure at 2477304.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 19.35% year-over-year to 2477304.0; the trailing twelve-month figure through Mar 2026 stood at 10629667.0 (down 3.85% YoY), and the FY2025 full-year result was 11224125.0, down 10.22% from the prior year.
- Cash from Operations for Q1 2026 stood at 2477304.0, up from 2892611.0 in the prior quarter.
- The five-year high for Cash from Operations was 1304348.0 in Q1 2023, with the low at 3071762.0 in Q1 2025.
- Historically, Cash from Operations has averaged 2367027.2 across 5 years, with a median of 2475584.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations plunged 131.53% — and 2026, when it gained 19.35%.
- Azitra's Cash from Operations stood at 2172692.0 in 2022, then declined by 16.87% to 2539207.0 in 2023, then declined by 1.85% to 2586201.0 in 2024, then decreased by 11.85% to 2892611.0 in 2025, then advanced by 14.36% to 2477304.0 in 2026.
- The last three Cash from Operations figures came in at 2477304.0 (Q1 2026), 2892611.0 (Q4 2025), and 2431514.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.48 Mn |
| Mar 31, 2026 | -2.48 Mn |
| Dec 31, 2025 | -2.89 Mn |
| Dec 31, 2025 | -2.89 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.83 Mn |
| Jun 30, 2025 | -2.83 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |